viewPhimedix PLC

Phimedix PLC - Notice of AGM and AIM Rule 15 Update

RNS Number : 7997Y
Phimedix PLC
11 September 2020

11 September 2020

Phimedix Plc

("Phimedix" or "the Company")


Notice of Annual General Meeting and AIM Rule 15 Update


Phimedix (AIM: PHM) confirms that the Annual Report & Accounts for the year ended 31 March 2020, together with the Notice of its Annual General Meeting ("AGM") and Form of Proxy, have been posted to shareholders and are available on the Company's website www.phimedix.com. The AGM is to be held at 10.00 a.m. on 5 October 2020, at Bracher Rawlins LLP, 77 Kingsway, London WC2B 6SR.


In accordance with Government legislation and related restrictions in response to COVID-19, and to minimise public health risks, the General Meeting is to be held as a closed meeting unless both the coronavirus (COVID-19) situation and the applicable guidance have changed prior to the date of the meeting. Unless Shareholders are notified otherwise by the Company prior to the date of the General Meeting, the arrangements for the meeting shall be that neither Shareholders, nor their proxies nor corporate representatives will be permitted to attend the meeting in person.  As such, Shareholders are strongly encouraged to appoint the Chairman of the General Meeting to act as their proxy as no other person will be permitted to attend the meeting.


AIM Rule 15 update


The London Stock Exchange is expected to suspend trading in the Company's ordinary shares on AIM, pursuant to Rule 15 of the AIM Rules, at 7.30 am on 14 September 2020.  In the event that no reverse takeover is completed in the six months after that date, the London Stock Exchange will cancel the admission of the Company's ordinary shares to trading on AIM. 




Phimedix Plc

Nicholas Nelson, Director

Ajay Rajpal, Director

Please email any enquiries to [email protected]


SPARK Advisory Partners Limited (Nominated Adviser)

Mark Brady or Neil Baldwin



+44 (0) 203 368 3550


SI Capital Ltd (Broker)

Nick Emerson



+44 (0)1483 413500



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

Quick facts: Phimedix PLC

Price: -

Market: AIM
Market Cap: -

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


3 min read